1. Academic Validation
  2. PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly

PARP4 ADP-ribosylates PIDD1 to complete a phospho/SUMO/PAR-ylation cascade that orchestrates PIDDosome assembly

  • Sci Adv. 2026 May;12(18):eadz9284. doi: 10.1126/sciadv.adz9284.
Richa B Shah 1 2 Yuanyuan Li 1 2 Ashley Person 3 Léonie Frigon 4 Nina Ðukić 5 Ela Kini 1 2 Raymond Chen 1 2 John M Pascal 4 Michael S Cohen 3 Ivan Ahel 5 John D Haley 6 Samuel Sidi 1 2 7
Affiliations

Affiliations

  • 1 Department of Medicine, Division of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • 2 Department of Cell, Developmental and Regenerative Biology, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • 3 Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, OR, USA.
  • 4 Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, Canada.
  • 5 Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • 6 Department of Pathology Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
  • 7 Department of Oncological Sciences, Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract

Adenosine diphosphate (ADP) ribosylation (ADPr) regulates multiple stress responses, yet substrates in the apoptotic machinery remain elusive. We show that a single, DNA damage-induced ADPr event controls proapoptotic PIDDosome (PIDD1/RAIDD/caspase-2) formation in response to unresolved interstrand DNA cross-links (ICL). ADPr targets conserved E783 in the PIDD1 death domain (DD); is catalyzed by poly(ADP-ribose) polymerase 4 (PARP4), a phylogenetically orphan PARP of previously unknown function; is reversed by the ribosylhydrolase activity of PARP14; and is triggered by Ataxia Telangiectasia and RAD3-related (ATR) phosphorylation-induced, PIAS1-mediated SUMOylation of the PIDD1 DD, which enables PARP4 docking. PIDD1 ADPr is dispensable for the recruitments of RAIDD and caspase-2 but essential for the dimerization of the Caspase. Hence, denying E783 ADPr spares the onset of PIDDosome assembly but blocks its completion, thus eliminating caspase-2 activation and ensuing Apoptosis. Conversely, removal of PARP14 forces Apoptosis, even in cells with tolerable damage. The data identify PARP4 as an ICL response effector and illuminate a three-step modification sequence of the PIDD1 DD that conducts PIDDosome assembly from initiation to completion.

Figures
Products